Literature DB >> 6653918

Serum concentrations of bile acid glucuronides in hepatobiliary diseases.

H Takikawa, H Otsuka, T Beppu, Y Seyama, T Yamakawa.   

Abstract

Bile acid glucuronides in the serum in various hepatobiliary diseases (36 cases) were quantitated by mass fragmentography and their clinical significance was discussed. Serum was added to defined amounts of deuterium-labeled bile acids and their glucuronide and sulfate derivatives, and the bile acids were separated into unconjugated, glucuronidated and sulfated groups after enzymatic cleavage of amide bonds. The liberated bile acids were quantitated by mass fragmentography. Bile acid glucuronides comprised about 7-8% of the total bile acids in the serum of various patients. Chenodeoxycholic acid was the major glucuronidated bile acid while cholic acid was mostly unconjugated. Lithocholic acid was almost all either sulfated or glucuronidated. In patients with obstructive jaundice, glucuronidated bile acids also comprised about 5%, although their absolute amounts were increased. In patients with liver cirrhosis, bile acid glucuronides were decreased, especially in decompensated cases, possibly as a result of hepatocellular dysfunction.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6653918     DOI: 10.1159/000198952

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  16 in total

1.  Quantitative-profiling of bile acids and their conjugates in mouse liver, bile, plasma, and urine using LC-MS/MS.

Authors:  Yazen Alnouti; Iván L Csanaky; Curtis D Klaassen
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-09-03       Impact factor: 3.205

2.  Enzymatic determination of serum 3 alpha-sulfated bile acids concentration with bile acid 3 alpha-sulfate sulfohydrolase.

Authors:  T Kato; M Yoneda; K Nakamura; I Makino
Journal:  Dig Dis Sci       Date:  1996-08       Impact factor: 3.199

3.  Bile acids increase intracellular Ca(2+) concentration and nitric oxide production in vascular endothelial cells.

Authors:  T Nakajima; Y Okuda; K Chisaki; W S Shin; K Iwasawa; T Morita; A Matsumoto; J I Suzuki; S Suzuki; N Yamada; T Toyo-Oka; R Nagai; M Omata
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

4.  Sinusoidal efflux of taurocholate is enhanced in Mrp2-deficient rat liver.

Authors:  H Akita; H Suzuki; Y Sugiyama
Journal:  Pharm Res       Date:  2001-08       Impact factor: 4.200

5.  Hepatic and extrahepatic glucuronidation of bile acids in man. Characterization of bile acid uridine 5'-diphosphate-glucuronosyltransferase in hepatic, renal, and intestinal microsomes.

Authors:  S Matern; H Matern; E H Farthmann; W Gerok
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

6.  Bile acids increase cellular free calcium in cultured kidney cells (LLC-PK).

Authors:  M H Montrose; R Lester; P Zimniak; M S Anwer; H Murer
Journal:  Pflugers Arch       Date:  1988-07       Impact factor: 3.657

7.  Urinary concentrations of bile acid glucuronides and sulfates in hepatobiliary diseases.

Authors:  H Takikawa; T Beppu; Y Seyama
Journal:  Gastroenterol Jpn       Date:  1984-04

Review 8.  Lipid-activated transcription factors control bile acid glucuronidation.

Authors:  Olivier Barbier; Jocelyn Trottier; Jenny Kaeding; Patrick Caron; Mélanie Verreault
Journal:  Mol Cell Biochem       Date:  2009-01-07       Impact factor: 3.396

Review 9.  Bile Acid Metabolism and Signaling in Cholestasis, Inflammation, and Cancer.

Authors:  Tiangang Li; Udayan Apte
Journal:  Adv Pharmacol       Date:  2015-05-27

10.  Glucuronidated and sulfated bile acids in serum of patients with acute hepatitis.

Authors:  H Takikawa; T Beppu; Y Seyama; T Sugimoto
Journal:  Dig Dis Sci       Date:  1986-05       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.